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Research
Secondhand smoke (SHS) is a combination 
of smoke emitted from a burning tobacco 
product and the smoke exhaled by the smoker 
[Department of Health and Human Services 
(DHHS) 1986]. Scientific evidence contin-
ues to show that SHS exposure is causally 
associated with lung cancer among never-
smokers or among nonsmokers (Vineis et al. 
2007). Secondhand smoke increases the risk 
of cardio vascular disease by approximately 
30% (Barnoya and Glantz 2005) and the risk 
of respiratory diseases (Flouris et al. 2009).
The increasing and overwhelming body 
of evidence that demonstrates elevated dis-
ease risk among nonsmokers exposed to SHS 
has led to the passage of smoking bans in 
workplaces and public places, including res-
taurants and bars. Smoke-free air laws have 
been very effective in reducing exposures 
to constituents of SHS (Bondy et al. 2009) 
as well as decreasing SHS-related diseases 
(Herman and Walsh 2010). In 2005, the 
state of Georgia passed a state-wide smok-
ing ban in restaurants and bars that serve 
or employ minors (Georgia Smoke-free 
Air Act 2005). Athens-Clarke County in 
Georgia further implemented an ordinance 
in 2005 prohibiting smoking in all restau-
rants and bars but not in all workplaces 
(Athens-Clarke County, Georgia, Code of 
Ordinances, Section 4.3, 2005).
Despite large positive effects of smoke-
free air laws on public health, indoor smoking 
bans seem to result in increased smoking out-
side establishments, in outdoor seating areas, 
or near the entrances of such establishments. 
The magnitude of outdoor SHS exposure and 
associated health risks are relatively unknown 
as very few studies have charac terized outdoor 
SHS exposure [California Air Resources Board 
(CARB) 2005; Kaufman et al. 2010; Klepeis 
et al. 2007; St.Helen et al. 2011)]. Systemic 
human exposure estimates from environ-
mental markers reported in these studies are 
subject to factors such as proximity to smokers 
and meteorological conditions and may be 
highly imprecise (Benowitz 1999). We also 
previously reported the first bio monitoring of 
nonsmokers exposed to outdoor SHS using 
salivary cotinine in a pilot study (Hall et al. 
2009). Cotinine is the primary proximate 
metabolite of nicotine.
Secondhand smoke contains carcino-
genic tobacco-specific nitrosamines (TSNA) 
such as 4-(methylnitrosamino)-1-(3-pyridyl)-
1- butanone (NNK) (Hoffmann and Hecht 
1990). Uptake of NNK by nonsmokers 
exposed to SHS has been identified as a bio-
chemical link between SHS exposure and lung 
cancer risk (DHHS 2006). NNK is mainly 
metabolized to 4-(methylnitrosamino)- 
1-(3-pyridyl)- 1-butanol (NNAL) and the 
glucuronide conjugate (NNAL-Gluc) (Hecht 
1996). Although cotinine is appropriate as 
a biomarker of SHS exposure it may not 
always be an accurate measure of exposure 
to some toxicants in tobacco smoke such as 
NNK (Benowitz et al. 2010), and thus under-
estimate SHS health risks. No studies have 
reported NNAL levels in nonsmokers who 
were exposed to outdoor SHS.
In this study, we used salivary cotinine 
to characterize the exposure of nonsmokers 
to SHS in outdoor seating areas and outside 
a restaurant and a bar in Athens, Georgia, 
where only indoor smoking is banned, and 
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Background: With an increase in indoor smoking bans, many smokers smoke outside  establishments 
and near their entrances, which has become a public health concern.
oBjectives: We characterized the exposure of nonsmokers to secondhand smoke (SHS) outside a 
restaurant and bar in Athens, Georgia, where indoor smoking is banned, using salivary cotinine and 
urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
Methods: In a crossover study, we assigned 28 participants to outdoor patios of a restaurant and a bar 
and an open-air site with no smokers on three weekend days; participants visited each site once and 
stayed for 3 hr. We collected saliva and urine samples immediately before and after the visits (post-
exposure) and on the following morning and analyzed samples for cotinine and total NNAL, respec-
tively. Regression models were fitted and changes in biomarkers were contrasted between locations.
results: Postexposure and pre exposure geometric mean salivary cotinine concentrations differed by 
0.115 ng/mL [95% confidence interval (CI): 0.105, 0.126)] and by 0.030 ng/mL (95% CI: 0.028, 
0.031) for bar and restaurant visits, respectively. There were no significant post- and pre exposure dif-
ferences in cotinine levels after control site visits, and changes after bar and restaurant site visits were 
significantly different from changes after control site visits (p < 0.001). Results comparing next-day 
and pre exposure salivary cotinine levels were similar. Next-day creatinine-corrected urinary NNAL 
concentrations also were higher than pre exposure levels following bar and restaurant visits [1.858 pg/
mg creatinine higher (95% CI: 0.897, 3.758) and 0.615 pg/mg creatinine higher (95% CI: 0.210, 
1.761), respectively], and were significantly different from changes after the control visits (p = 0.005).
conclusion: Salivary cotinine and urinary NNAL increased significantly in nonsmokers after out-
door SHS exposure. Our findings indicate that such exposures may increase risks of health effects 
associated with tobacco carcinogens.
key words: NNAL, outdoor secondhand smoke, salivary cotinine, smoking bans, tobacco nitro-
samines. Environ Health Perspect 120:1010–1016 (2012). http://dx.doi.org/10.1289/ehp.1104413 
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urinary NNAL to characterize their uptake 
of TSNA. 
Materials and Methods
Study location. We conducted this crossover 
study during three weekends in August and 
September 2010 in the college town of Athens, 
Georgia. Three locations were selected—out-
door seating or standing areas of a bar and a 
family restaurant where indoor smoking was 
banned, but both establishments had no restric-
tions on outdoor smoking, and an open air 
seating area outside the Environmental Health 
Science (EHS) building at the University of 
Georgia (UGA) with no smokers present. 
Descriptions of the study sites are presented in 
Table 1. The bar was selected based on previ-
ous data showing relatively high SHS outside 
this site (Hall et al. 2009; St.Helen et al. 2011). 
Although we previously measured lower SHS 
at family restaurants in Athens, Georgia, (Hall 
et al. 2009; St.Helen et al. 2011), we included a 
restaurant site in the present study because res-
taurants may serve as potential SHS sources to 
children and individuals who do not visit bars.
Participant recruitment and selection. 
Participants were UGA college students. We 
administered a questionnaire, designed by our 
research team, to determine the elibility of 
potential participants. Questions included cur-
rent and past smoking status and current SHS 
exposure at home, work, or elsewhere. Eligible 
participants were healthy males and females 
21–40 years of age who did not use tobacco or 
nicotine in any form, females were not or could 
not be pregnant, and enrollment was directed 
to a target sample size of 24 participants. 
Respondents who met the eligibility require-
ments attended personal information sessions 
in which the study and protocol were discussed 
and concerns or questions were addressed. 
The study was designed as a crossover study in 
which participants visited each site once dur-
ing each of the 3 weeks of the study (i.e, once 
each at the bar and restaurant sites and at the 
control site). The order of site visits was based 
on a replicated Latin square (Fleiss 1986) [see 
Supplemental Material, Table 1 (http://dx.doi.
org/10.1289/ehp.1104413)]. Twenty-eight 
participants were enrolled in the study; each 
gave written informed consent before partici-
pating. The institutional review boards at 
UGA and the Centers for Disease Control and 
Prevention (CDC) approved the study.
Site visits. We asked participants to avoid 
all SHS as much as possible 3 days prior to 
each study weekend. Participants arrived at the 
EHS building about 1 hr before site visits. We 
collected pre exposure saliva and urine samples 
from the participants. They were transported 
to the restaurant and bar sites on a non-
smoking EHS van. On study days, the partici-
pants visited the restaurant site and the control 
site at 1800–2100 hours and the bar site at 
2300–0200 hours. Participants remained at 
each study site for the full 3 hr except for nec-
essary bathroom breaks; they were encouraged 
to stand or sit in close proximity to smokers, 
which ranged from about 0.5 m to 5 m at any 
given time. Participants ate dinner while they 
were at the restaurant and control site and 
ate dinner before visits to the bar site. One 
participant at each location [a lab technician 
or graduate student in the EHS Air Quality 
Lab (AQL) who was familiar with the study 
protocol] was assigned to count and record 
the number of cigarettes that were lit during 
every 10-min period of the 3-hr visit. After 
the 3-hr visit, participants at the control site 
returned to the EHS building, and those at 
the restaurant and bar sites were transported 
on the EHS van. We collected post exposure 
saliva and urine samples within 30 min of 
participants leaving the study sites to assess 
the exposure of the participants to SHS for the 
48-hr period before the site visits.
Biological sample collection. Participants 
provided saliva and urine samples immediately 
before and after site visits (referred to as pre-
exposure and post exposure samples, respec-
tively) to AQL staff at the EHS building. In 
addition, participants collected saliva and urine 
(first-morning void) at their homes on the next 
day (referred to as next-day samples), that were 
kept frozen until delivery by the participants 
to EHS on the Monday following each study 
weekend. Salivettes (Sarstedt, Newton, NC) 
were used to collect saliva samples. Participants 
were provided labeled urine sampling cups and 
salivettes for next-day sampling after the post-
exposure samples were collected. Samples were 
stored in a –80oC freezer at EHS until they 
were shipped on dry ice to the CDC (Atlanta, 
GA) for analyses of salivary cotinine and uri-
nary NNAL and creatinine 6 weeks after the 
end of the study.
Biomarker analysis. Salivary cotinine was 
measured by high-performance liquid chro-
matography–atmospheric-pressure chemical 
ionization–tandem mass spectrometry (LC 
APCI MS/MS) using a method described else-
where (Bernert et al. 2000); the limit of detec-
tion (LOD) was 15 pg/mL). We measured 
total NNAL (free plus conjugated) with high-
performance liquid chromatography coupled 
with electrospray-ionization–tandem mass 
spectrometry using a method that has been 
described in Xia and Bernert (2010; LOD 
0.6 pg/mL). We measured creatinine in urine 
by a commercially available colorimetric enzy-
matic method (Creatinine plus, version 2; 
Roche Diagnostics Corp, Indianapolis, IN) 
implemented on a Roche/Hitachi Modula P 
Chemistry Analyzer (Roche Diagnostics).
Statistical analysis. Because salivary cotinine 
and urinary NNAL values were not normally 
distributed, we computed geometric mean con-
centrations and used log-transformed values in 
regression analyses. Differences in geometric 
means and 95% confidence intervals (CIs) of 
pre exposure, post exposure, and next-day bio-
marker levels were computed and used to rep-
resent changes in biomarker data after visits to 
each of the three sites. When biomarker levels 
were below their respective LODs, we used 
the reported concentrations obtained from the 
assays for cotinine and NNAL cited above. Our 
analyses were performed for both uncorrected 
and creatinine-corrected urinary NNAL.
We used regression analysis to contrast the 
changes in log-transformed biomarker levels 
from the pre exposure samples to the post-
exposure and next-day samples according to 
location. For response yijk measured on the 
kth participant on the jth measurement occa-
sion (day) under the ith exposure location, 
Equation 1 was assumed. In this study design, 
participants were assigned only 1 of 2 weekend 
days (Friday or Saturday), thus, day was nested 
in week (w(j)l):
 yijk = μi + w(j)l + sk + eijk, [1]
where μi represents the mean response for the 
ith exposure location, and w(j)l and sk are mean 
zero, constant variance, normal random effects 
for day nested in weeks and participants, respec-
tively. To include nondetectable concentrations 
of NNAL (zero concentration) in regression 
analyses, we added a small number (10–7) to all 
NNAL values before log transformation. We 
conducted F-tests of no overall effect of exposure 
Table 1. Description of study sites.
Site Bar Restaurant Control
Description Bar with outdoor patio on second 
floor; partially enclosed by two 
walls of adjacent buildings, 
open at one end with no roof
Family restaurant with 
large open-air patio
Open-air seating
Location Downtown Athens, GA; 5 min 
from UGA’s EHS building
Athens west; 10 min 
from EHS
Outside EHS building
No. of tables 6 17 5
Approximate outdoor area (m2) 176 549 NA
Cigarette counta
Mean ± SD 144.5 ± 39.9 33.5 ± 28.0 0
Minimum–Maximum 86–202 12–86 0
NA, not applicable.
aCigarette count computed from 3-hr sums of 10-min cigarette count. 
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location as well as pair-wise contrasts between 
the control, restaurant, and bar locations, respec-
tively, adjusted by Tukey’s method for multiple 
comparisons. To assess whether there was a car-
ryover effect in biomarker response after SHS 
exposure from week to week, we conducted a 
repeated measures analysis on pre exposure bio-
marker levels and contrasts were made across 
the 3 study weeks. Further, to examine the effect 
of number of cigarettes smoked at the different 
locations on changes in biomarker concentra-
tions, we replaced the location variable shown in 
equation 1 with smoker count (total number of 
cigarettes counted over the 3-hr study period) in 
a second set of models.
Spearman rank correlation coefficients 
between changes in cotinine, NNAL, and 
creatinine-corrected NNAL were computed. 
Although cotinine is generally used as a bio-
marker of tobacco smoke exposure, it has not 
been shown to have adverse health effects. On 
the other hand, NNAL has comparable carcino-
genic potency as its parent compound, NNK. 
Thus, it is important to determine the association 
between cotinine and NNAL after outdoor SHS 
exposure. Also, the ratio of NNAL to cotinine is 
of potential interest as a biomarker to discrimi-
nate passive from active smokers (Goniewicz 
et al. 2011). Thus, we examined differences in 
this ratio across locations using Kruskal–Wallis 
test [see Supplemental Material, Table 2 
(http://dx.doi.org/10.1289/ehp.1104413)].
Table 2. Salivary cotinine and urinary NNAL in nonsmokers after visits to outdoor locations.
Analyte Location Variable Pre exposure Postexposure Next day
Cotinine (ng/mL) Control n 26 26 26
Range 0.019–0.480 0.021–0.434 0.024–0.359
GM 0.049 0.044 0.053
95% CIa 0.037, 0.063 0.034, 0.058 0.041, 0.070
Restaurant n 27 23 25
Range 0.011–0.165 0.036–0.188 0.029–0.181
GM 0.046 0.075 0.069
95% CI 0.036, 0.058 0.064, 0.089 0.058, 0.082
Bar n 27 25 26
Range 0.015–0.356 0.094–0.407 0.035–0.444
GM 0.045 0.161 0.165
95% CI 0.035, 0.059 0.140, 0.184 0.136, 0.200
NNAL (pg/mL) Control n 27 27 26
Range 0 –11.3 0–6.900 0–6.300
GM 0.033 0.050 0.038
95% CI 0.005, 0.203 0.008, 0.302 0.005, 0.263
C-C NNAL (pg/mg creatinine) Range 0–4.061 0–2.724 0–3.099
GM 0.038 0.057 0.030
95% CI 0.007, 0.191 0.012, 0.285 0.005, 0.198
NNAL (pg/mL) Restaurant n 27 27 27
Range 0–10.900 0–2.100 0–7.300
GM 0.041 0.008 0.774
95% CI 0.007, 0.239 0.001, 0.047 0.268, 2.234
C-C NNAL (pg/mg creatinine) Range 0–15.875 0–1.921 0–10.501
GM 0.056 0.013 0.671
95% CI 0.011, 0.274 0.002, 0.069 0.221, 2.035
NNAL (pg/mL) Bar n 27 27 27
Range 0–10.200 0–3.600 0–10.400
GM 0.037 0.109 2.407
95% CI 0.007, 0.206 0.023, 0.503 1.068, 5.425
C-C NNAL (pg/mg creatinine) Range 0–95.500 0–3.749 0–6.113
GM 0.039 0.182 1.898
95% CI 0.007, 0.229 0.044, 0.755 0.904, 3.986
Abbreviations: C-C, creatinine corrected; GM, geometric mean; n, number of participants.
a95% CI of geometric means.
Figure 1. Salivary cotinine (ng/mL) for control, restaurant, and bar (A, B, and C, respectively), urinary uncorrected NNAL (pg/mL) for control, restaurant, and bar 
(D–F), and creatinine-corrected NNAL (pg/mg creatinine) for control, restaurant, and bar (G–I) measured pre exposure, immediately after 3-hr SHS exposure, and 
in first-void next-day samples of participants (n = 27). Blue boxes represent third quartiles, black lines in the boxes are medians, gray boxes are first quartiles, and 
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Finally, because nondetectable concentra-
tions and below LODs made up 28.9% and 
14.9%, respectively, of the 242 urine samples 
analyzed for NNAL, we used Friedman’s non-
parametric chi-square test (Friedman 1937) as 
a sensitivity analysis treating pre exposure, post-
exposure, and next-day urinary NNAL values 
as repeated measures on participants. We used 
SAS software (version 9.1; SAS Institute, Inc. 
Cary, NC) to perform the analyses, and all 
statistical tests were considered significant at 
α = 0.05.
Results
We recruited 28 participants for the study 
(18 females). Of these, 17 were white 
(11 female), 7 were black (3 females), 3 were 
Asian (all female), and 1 described her race 
as other. All participants were 21–37 years of 
age. We excluded one participant who had a 
baseline (pre exposure before first site visit) sali-
vary cotinine concentration of 5.25 ng/mL—a 
concentration characteristic of very high SHS 
exposure or occasional smoking. This individ-
ual lived with a smoker. Otherwise, the range 
of pre exposure salivary cotinine concentrations 
in samples provided before the first study visit 
confirmed that prestudy SHS exposures were 
low (0.011–0.480 ng/mL).
Biomarker levels according to sample and 
site. One participant did not provide next-
day saliva and urine samples. Also, 11 of the 
242 samples collected did not have enough 
saliva for cotinine analysis (n = 1 pre exposure, 
n = 7 post exposure, and n = 3 next-day) 
and 1 sample was below the LOD (0.015 
ng/mL). Geometric means of pre exposure, 
post exposure, and next-day salivary coti-
nine levels are presented in Table 2; quartiles 
and 95th percentiles of salivary cotinine for 
these sampling time points are presented in 
Figure 1A–C. Although salivary cotinine levels 
remained flat after participants visited the con-
trol site, salivary cotinine levels increased, as 
expected, after restaurant and bar visits, with 
greater increases after bar visits. Salivary coti-
nine concentrations in post exposure and next-
day samples were similar. One participant’s 
postexposure – pre exposure change in salivary 
cotinine reached 0.4 ng/mL after the bar visit.
For the 27 participants at baseline, 
NNAL was measured above the LOD in 9 
(33.3%), below the LOD in 10 (37.0%), 
and not detected in 8 (29.6%). Overall, of 
242 urine samples collected during the study 
period from 27 participants (81 pre exposure, 
81 post exposure, and 80 next-day samples, 
1 did not provide a next-day urine sample), 
urinary NNAL was measured above the LOD 
in 56.2% (n = 136), below the LOD in 14.9% 
(n = 36), and not detected in 28.9% (n = 70). 
Geometric means for uncorrected and crea-
tinine-corrected pre exposure, post exposure, 
and next-day urinary NNAL are presented in 
Table 2, and quartiles and 95th percentiles 
are illustrated in Figure 1D–I. Urinary NNAL 
concentrations remained flat after visits to the 
control site. There was also a lack of change 
between previsit and postvisit restaurant and 
bar samples, respectively, in contrast to changes 
noted for next-day restaurant and bar samples. 
As expected, larger changes in urinary NNAL 
levels were observed in next-day samples after 
visits to the bar site.
Differences in biomarker responses between 
sites. Regression models to test differences 
in biomarkers after exposure between sites 
excluded two participants whose samples were 
not collected according to their preassigned 
sequence because of personal scheduling con-
flicts, and one participant who did not com-
plete all three visits. As a result, we had eight 
complete Latin squares with three participants 
per square (24 participants total).
Mean differences in post exposure versus 
pre exposure salivary cotinine concentrations 
were significantly greater after visits to the 
bar location [0.115 ng/mL (95% CI: 0.105, 
0.126)] and restaurant location [0.030 ng/mL 
(95% CI: 0.028, 0.031)] relative to changes 
Figure 2. Saliva-cotinine and urinary-NNAL changes after a 3-hr visit to outdoor seating areas of a restau-
rant and a bar where outdoor smoking was allowed and to an open-air control location with no smokers. 
(A) Salivary cotinine postexposure minus pre exposure (ng/mL). (B) Salivary cotinine next-day minus pre-
exposure (ng/mL). Urinary uncorrected (pg/mL) and creatinine-corrected postexposure minus pre exposure 
NNAL (pg/mg creatinine) (C), and urinary uncorrected (pg/mL) and creatinine-corrected (pg/mg creatinine) 
next-day minus pre exposure NNAL (D). Values represent differences in geometric means and 95% CIs.
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Table 3. Test of effect of exposure location and pair-wise comparisons between location types.
Analyte
Response 
variable Fixed effect and comparisons Estimatea SE




Fixed effect Location 76.72 < 0.001
Comparisonsc Restaurant vs. control 0.264 0.049 5.32 < 0.001
Bar vs. control 0.596 0.048 12.36 < 0.001
Bar vs. restaurant 0.334 0.049 6.72 < 0.001
NNAL Fixed effect Location 1.62 0.210
C-C NNAL Fixed effect Location 2.05 0.142
Cotinine log(next-day) 
– log(pre)
Fixed effect Location 40.99 < 0.001
Comparisonsc Restaurant vs. control 0.180 0.065 2.75 0.008
Bar vs. control 0.570 0.064 8.83 < 0.001
Bar vs. restaurant 0.390 0.065 6.05 < 0.001
NNAL Fixed effect Location 6.30 0.004
Comparisonsc Restaurant vs. control 1.458 0.561 2.60 0.012
Bar vs. control 1.915 0.561 3.42 < 0.001
Bar vs. restaurant 0.456 0.548 0.83 0.411
C-C NNAL Fixed effect Location 6.16 0.005
Comparisonsc Restaurant vs. control 1.370 0.552 2.48 0.001
Bar vs. control 1.884 0.552 3.41 < 0.001
Bar vs. restaurant 0.553 0.541 0.95 0.348
C-C, creatinine corrected.
aDifference in least square means on log10 scale (when back-transformed, represents a ratio of concentrations of 
biomarkers between sites). bF-value applies to fixed effects test, whereas t-values apply to pair-wise comparisons; pair-
wise comparisons were not made when overall F tests were nonsignificant; cp-Values adjusted for multiple comparisons 
(Tukey’s method).
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observed after visiting the control site 
[–0.004 ng/mL (95% CI –0.005, –0.003)] 
(Figure 2A), with p < 0.001 for both compari-
sons based on regression models (Table 3). 
We obtained similar results when we looked 
at next-day versus pre exposure concentrations 
(Table 3, Figure 2B).
As noted above, there were no significant 
differences in urinary (uncorrected and crea-
tinine-corrected) NNAL concentrations for 
samples collected immediately after site visits 
compared with previsit samples, regardless of 
site (Figure 1D-I). Consistent with expecta-
tions, there also were no significant differences 
in changes observed between sites (Figure 2C). 
However, contrasts between next-day and 
previsit uncorrected and creatinine-corrected 
urinary NNAL concentrations were signifi-
cantly greater after visits to the bar location 
(p < 0.001) and restaurant location (p = 0.006) 
compared with the control site (Table 3, 
Figure 2D). Further, when we analyzed pre-
exposure, post exposure, and next-day NNAL as 
repeated measures (Friedman's nonparametric 
chi-square test), location type had a significant 
effect on the distribution of urinary NNAL 
(uncorrected: χ2 = 7.16, p = 0.028; creatinine 
corrected: χ2 = 13.9, p = 0.001). These results 
are consistent with those presented above.
Differences in weekly pre exposure bio­
markers (crossover effect). Compared with 
baseline average salivary cotinine levels 
[0.038 ng/mL (95% CI: 0.029, 0.049)], week-3 
pre exposure salivary cotinine was significantly 
higher [0.055 ng/mL (95% CI: 0.043, 0.071); 
p = 0.006]. Average week-2 pre exposure sali-
vary cotinine levels [0.045 ng/mL (95% CI: 
0.035, 0.058)] were not significantly different 
from baseline (p = 0.416). Pre exposure urinary 
NNAL did not differ significantly during the 
3 weeks of the study (uncorrected, p = 0.778; 
creatinine corrected, p = 0.169). Weeks 1, 2, 
and 3 geometric means and 95% CI for pre-
exposure creatinine-corrected NNAL were as 
follows: 0.5 (95% CI: 0.3, 0.7), 0.8 (95% CI: 
0.5, 1.2), and 0.7 (95% CI: 0.5, 1.1) pg/mg 
creatinine, respectively.
Biomarkers versus cigarette counts. On 
average, we counted a higher number of lit 
cigarettes over the 3-hr sampling period outside 
the bar (mean ± SD, 144.5 ± 39.9) than outside 
the restaurant (mean ± SD, 33.5 ± 28.0). No 
lit cigarettes were observed at the control site. 
The effect of cigarette count on post exposure 
minus pre exposure changes in salivary cotinine 
[0.0032 (0.0003), presented as effect estimate 
and SE] and on next-day minus pre exposure 
changes in salivary cotinine [0.0032 (0.0004)] 
were significant (both p <0.001). Just as with 
location type, cigarette count was not asso-
ciated with post exposure minus pre exposure 
changes in urinary uncorrected and creatinine-
corrected NNAL but was significantly associ-
ated with next-day minus pre exposure changes 
in uncorrected NNAL [0.0003 (0.0007)] and 
creatinine-corrected NNAL [0.0032 (0.0008)] 
(both p = 0.018).
Salivary cotinine versus urinary NNAL 
correlations and ratios. Changes in salivary 
cotinine were generally moderately corre-
lated to changes in urinary NNAL (uncor-
rected and creatinine corrected); higher 
correlations were observed between changes 
in post exposure – pre exposure and next-
day – pre exposure salivary cotinine and in 
next-day – pre exposure changes in NNAL 
(Table 4). Although the ratios of urinary 
NNAL to salivary cotinine did not differ sig-
nificantly across location type, ratios were 
lower in post exposure samples compared 
to pre exposure and next-day samples [see 
Supplemental Material, Table 2 (http://dx.doi.
org/10.1289/ehp.1104413)].
Discussion
In this study, we investigated the uptake of 
tobacco-specific compounds in 27 non smokers 
after they were exposed to SHS outside a restau-
rant and a bar in Athens, Georgia. We observed 
significant increases in cotinine measured in 
saliva collected both immediately after and the 
morning after the 3-hr visits outside bar and res-
taurant sites, and observed significant increases 
in urinary NNAL (uncorrected and creatinine 
corrected) measured in urine collected at first-
morning void after bar and restaurant site vis-
its. In contrast, there were minimal changes in 
biomarker levels after 3-hr visits to a control 
location without smokers present. The changes 
in salivary cotinine and urinary NNAL mea-
sured after visits to bar and restaurant locations 
were significantly greater than were changes 
after control site visits. In addition, we observed 
significant associations between the number of 
cigarettes smoked and changes in biomarker 
levels after visits.
Cotinine has been proposed as a very sen-
sitive and specific biological marker of SHS 
exposure (Benowitz 1999). Cotinine has an 
average half-life of 16 hr and is eliminated from 
the body within 3–4 days after the last expo-
sure (Benowitz 1996). Salivary cotinine was 
used in the current study instead of the com-
monly used serum cotinine because it is easier 
to collect. Previous studies have shown that 
serum and salivary cotinine levels are highly 
correlated with ratios ranging from 1.1 to 1.4 
(Curvall et al. 1990). We previously used sali-
vary cotinine to characterize uptake of SHS 
constituents in nonsmokers after a 6-hr visit 
to outdoor patios and seating areas of restau-
rants and bars (Hall et al. 2009). Geometric 
mean changes in salivary cotinine after vis-
its to outdoor patios of bars and restaurants 
were 0.114 ng/mL and 0.039 ng/mL, respec-
tively. These changes were significantly higher 
than those observed after visits to a control 
site (0.006 ng/mL) (Hall et al. 2009) and were 
similar to what we report in the current study, 
despite longer exposure times in the first study 
(6 hr compared with 3 hr). However, this find-
ing is consistent with expectations given that 
visits for the present study were timed to occur 
when smoking activity was highest at each site 
(1800–2100 hours and 2300–0200 hours) at 
the restaurant and bar sites, respectively).
To our knowledge, we are the first study 
to report changes in urinary NNAL concen-
trations following outdoor SHS exposure. 
NNAL is the metabolite of NNK. Both are 
systemic pulmonary carcinogens specific to 
tobacco smoke (Hecht 2003). There is strong 
evidence that NNK is a causative agent in the 
formation of lung adenocarcinoma in smok-
ers (Hoffmann et al. 1996), which is now the 
most frequent type of lung tumor found in 
nonsmokers (Hoffmann et al. 1996). Total 
NNAL has been used to characterize human 
exposure to carcinogenic tobacco-specific nit-
rosamines among nonsmokers with exposure 
to SHS (Anderson et al. 2001). In addition, 
epidemiologic studies linking lung cancer to 
SHS have been strengthened by the detection 
of NNAL in nonsmokers (DHHS 2006).
We observed significant increases in total 
uncorrected and creatinine-corrected NNAL 
measured in next-day first-void urine sam-
ples following both bar and restaurant site 
visits compared to the control site visit. The 
lack of changes in urinary NNAL immedi-
ately following exposure are consistent with 
elimination half-life of NNAL, which averages 
10–16 days (Goniewicz et al. 2009). Although 
NNAL concentrations measured in the current 
study were low, NNAL was detected above 
the LOD in 66 of the 80 next-day samples 















Next day – Pre
Cotinine (post – pre) 1 (75) 0.78* (73) 0.12 (75) 0.42* (74) 0.21 (75) 0.48* (74)
Cotinine (next day – pre) 1 (76) 0.22 (76) 0.49* (76) 0.33* (76) 0.60* (76)
NNAL (post – pre) 1 (81) 0.47* (80) 0.75* (81) 0.36* (80)
NNAL (next day – pre) 1 (80) 0.46* (80) 0.80* (80)
C-C NNAL (post – pre) 1 (81) 0.53* (80)
C-C NNAL (next day – pre) 1 (80)
C-C, creatinine-corrected urinary NNAL concentrations; next-day–pre, next-day minus pre exposure; post–pre, post-
exposure minus pre exposure. Number of observations are shown in parentheses.
*p < 0.001. 
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(83%) compared with 38 of the 81 (47%) 
post exposure and 32 of 81 (40%) pre exposure 
urine samples. Our results demon strate that 
nonsmokers with even brief SHS exposures 
(3 hr) may be exposed to detectable levels of 
tobacco-specific nitrosamines.
We observed significant but moderate 
correlations between salivary cotinine and 
next-day urinary NNAL showing that salivary 
cotinine from outdoor SHS exposure may not 
always be highly predictive of urinary NNAL 
concentrations. This may reflect differences 
in the metabolic rates of these compounds, as 
well as differences in internal doses received 
after exposure to the parent compounds in the 
ambient atmosphere. Unpublished research 
from the Philip Morris Tobacco Company 
showed that NNK was formed in sidestream 
smoke in a chamber and in indoor air hours 
after it was released (Schick and Glantz 2007) 
whereas air–nicotine concentrations decreased 
over time. Thus, as SHS ages, exposure to 
NNK can increase, while nicotine decreases. 
The extent to which this applies in outdoor 
locations is uncertain and needs further study. 
We also present novel data on the ratios 
between urinary NNAL and salivary cotinine 
in Supplemental Material (http://dx.doi.
org/10.1289/ehp.1104413).Although we did 
not see differences across locations, our results 
seem to indicate that the ratio of urinary 
NNAL to salivary cotinine is lower immedi-
ately following SHS exposure compared with 
before exposure and next-day. This seems 
to suggest that the NNAL to cotinine ratio 
may indicate time from last exposure, with 
low ratios signaling recent SHS exposures. 
Further investigation is needed to assess its 
 applicability.
Studies of indoor exposure to SHS among 
non smokers have previously reported changes 
in urinary NNAL ranging from 3.8 pg/mg cre-
atinine to 12.3 pg/mL (Anderson et al. 2003; 
Parsons et al. 1998), at least twice the next-
day – pre exposure changes in NNAL after the 
bar site visits reported here. However, by mea-
suring NNAL in first-morning void samples, 
it is likely that we underestimated NNAL 
changes after the bar visits relative to restaurant 
visits (i.e., shorter time from post exposure to 
next-day samples after bar visits compared to 
the restaurant visits). Also, the NNAL changes 
following bar visits we report here are at least 
two orders of magnitude lower than what has 
been measured in active smokers (Stepanov 
and Hecht 2005). Although the clinical signifi-
cance of outdoor SHS levels we present here 
are not fully known, asthmatic adults with low 
level outdoor SHS exposure measured using a 
nicotine badge (nicotine 0.03 μg/m3) showed 
increased risk of respiratory symptoms and 
extra bronchodilator use (Eisner et al. 2001). 
Personal air nicotine reported by Eisner et al. 
is not easily comparable with systemic cotinine 
and NNAL doses reported here. Studies have 
also shown significant cardio vascular effects of 
low level SHS exposure (Barnoya and Glantz 
2005). Repace et al. (1998) estimated an 
increased lifetime mortality risk of 1 per 1,000 
persons for lung cancer and 1 per 100 persons 
for heart disease from an average salivary coti-
nine of 0.4 ng/mL. Although average salivary 
cotinine levels from SHS exposure outside the 
bar were 25% of this estimated salivary coti-
nine level, one participant had an increase of 
0.4 ng/mL. Given that urinary and possibly 
salivary cotinine underestimate NNK exposure 
(Benowitz et al. 2010) and therefore cancer 
risk estimates, the NNAL levels reported here 
will help improve these disease risk estimates. 
The reported NNAL concentrations also raise 
concerns about hospitality workers who are 
potentially exposed to outdoor SHS for longer 
periods and more frequently during the week 
than the study participants.
The present study has several strengths 
and limitations. Among the strengths, we used 
a crossover design that controls for the high 
inter- and intra individual variability commonly 
observed in biomarker response. Further, this 
study is the first to report NNK exposure by 
measuring NNAL in nonsmokers exposed to 
outdoor SHS—results that could potentially 
have public health implications. On the other 
hand, one of the limitations of the study is the 
absence of objective proxies of SHS levels such 
as PM2.5, CO, or air nicotine. Instead we used 
cigarette count to assess SHS at each site, which 
showed an exposure response with biomarkers. 
Further, we did not collect variables such as 
temperature and wind speed at the study sites 
that would more accurately characterize expo-
sure because the study sites were different. Our 
results may not be generalizable to other sites 
of outdoor SHS exposure given that the extent 
of exposure will vary depending on the amount 
of smoking, ventilation, wind speed, and other 
factors. However, contrasts between the three 
sites do show differences according to moder-
ate and high exposures (at the restaurant and 
bar, respectively).
Finally, there is a possibility of carry-
over effect from week to week in biomarker 
response. No significant carryover effect was 
observed for NNAL, but we observed higher 
pre exposure salivary cotinine in week 3 com-
pared with baseline. It is possible that some 
participants had short unreported expo-
sures to SHS before study times in week 3. 
Nevertheless, as we investigated the changes 
between sampling time points, these response 
variables are less likely to be affected by 
 carryover effects.
Conclusions
Our results indicate that both salivary cotinine 
and urinary NNAL increased significantly fol-
lowing exposure to SHS outside of restaurants 
and bars in Athens, Georgia. Although 
 urinary total NNAL concentrations were 
rela tively low, they indicate that nonsmokers 
exposed to brief periods of SHS in outdoor 
locations may be exposed to measurable con-
centrations of carcinogenic tobacco-specific 
nitrosamines such as NNK. Because of the 
relatively long half-life of NNAL and much 
lower NNK exposure in passive smokers than 
in active smokers, future studies that investi-
gate outdoor SHS exposure should consider 
measuring NNAL in urine of  nonsmokers at 
≥ 24 hr post exposure.
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